Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

Clinical trial NCT04142970 · COMPLETED

Trial details

NCT number: NCT04142970
Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Renal Impairment

Start date: 2020-01-05
Primary completion: 2020-08-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.